Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
EGLN1/PHD2 Antibody, Alexa Fluor™ 405, Novus Biologicals™

Rabbit Polyclonal Antibody
Supplier: Novus Biologicals NB100138AF405
Description
EGLN1/PHD2 Polyclonal specifically detects EGLN1/PHD2 in Human, Rat, Mouse (Negative) samples. It is validated for Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin, Knockdown Validated.Specifications
EGLN1/PHD2 | |
Polyclonal | |
Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin, KnockDown Validated | |
Q9GZT9 | |
EGLN1 | |
Synthetic peptide made to a C-terminal portion of human PHD2/HIF Prolyl Hydroxylase 2 (between amino acids 350-426) (GeneID 54583). | |
Affinity Purified | |
RUO | |
Primary | |
Human. Does not appear to work in mouse. Rat reactivity reported in scientific literature (PMID: 17003483). | |
Store at 4C in the dark. |
Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin), KnockDown | |
Alexa Fluor 405 | |
50mM Sodium Borate with 0.05% Sodium Azide | |
C1orf12HPH2, EC 1.14.11, EC 1.14.11.-, ECYT3, egl nine homolog 1, egl nine homolog 1 (C. elegans), egl nine-like protein 1, HIF prolyl hydroxylase 2, HIF-PH2, HIFPH2 EGL nine (C.elegans) homolog 1, HIF-prolyl hydroxylase 2, HPH-2, Hypoxia-inducible factor prolyl hydroxylase 2, PHD2SM20, Prolyl hydroxylase domain-containing protein 2, SM-20, zinc finger MYND domain-containing protein 6, ZMYND6DKFZp761F179 | |
Rabbit | |
46 kDa | |
0.1 mL | |
Cancer, Chromatin Research, Hypoxia | |
54583 | |
Human, Rat, Mouse (Negative) | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction